| Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries V Boeva, C Louis-Brennetot, A Peltier, S Durand, C Pierre-Eugène, ... Nature genetics 49 (9), 1408-1413, 2017 | 420 | 2017 |
| KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression C Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, ... Oncogene 26 (1), 158-163, 2007 | 289 | 2007 |
| JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas O Mariani, C Brennetot, JM Coindre, N Gruel, C Ganem, O Delattre, ... Cancer cell 11 (4), 361-374, 2007 | 239 | 2007 |
| MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone F Dujardin, MBN Binh, C Bouvier, A Gomez-Brouchet, F Larousserie, ... Modern Pathology 24 (5), 624-637, 2011 | 231 | 2011 |
| Two types of chromosome 1p losses with opposite significance in gliomas A Idbaih, Y Marie, G Pierron, C Brennetot, K Hoang‐Xuan, M Kujas, ... Annals of neurology 58 (3), 483-487, 2005 | 186 | 2005 |
| BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency C Oliveira, M Pinto, A Duval, C Brennetot, E Domingo, E Espín, ... Oncogene 22 (57), 9192-9196, 2003 | 176 | 2003 |
| Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation E Domingo, E Espín, M Armengol, C Oliveira, M Pinto, A Duval, ... Genes, Chromosomes and Cancer 39 (2), 138-142, 2004 | 123 | 2004 |
| VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles PL Rosa, E Viara, P Hupe, G Pierron, S Liva, P Neuvial, I Brito, S Lair, ... Bioinformatics 22 (17), 2066-2073, 2006 | 120 | 2006 |
| Spatial normalization of array-CGH data P Neuvial, P Hupé, I Brito, S Liva, É Manié, C Brennetot, F Radvanyi, ... BMC bioinformatics 7, 1-20, 2006 | 116 | 2006 |
| The mutator pathway is a feature of immunodeficiency-related lymphomas A Duval, M Raphael, C Brennetot, H Poirel, O Buhard, A Aubry, A Martin, ... Proceedings of the National Academy of Sciences 101 (14), 5002-5007, 2004 | 104 | 2004 |
| Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma A Cazes, L Lopez-Delisle, K Tsarovina, C Pierre-Eugène, K De Preter, ... Oncotarget 5 (9), 2688, 2014 | 102 | 2014 |
| Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis V Boeva, S Jouannet, R Daveau, V Combaret, C Pierre-Eugene, A Cazes, ... PloS one 8 (8), e72182, 2013 | 96 | 2013 |
| Mononucleotide repeats BAT‐26 and BAT‐25 accurately detect MSI‐H tumors and predict tumor content: Implications for population screening C Brennetot, O Buhard, F Jourdan, JF Flejou, A Duval, R Hamelin International journal of cancer 113 (3), 446-450, 2005 | 74 | 2005 |
| Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma A Cazes, C Louis-Brennetot, P Mazot, F Dingli, B Lombard, V Boeva, ... Cancer research 73 (1), 195-204, 2013 | 69 | 2013 |
| The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well‐differentiated and dedifferentiated liposarcoma oncogenesis. An analysis of 104 tumors C Louis‐Brennetot, JM Coindre, C Ferreira, G Pérot, P Terrier, A Aurias Genes, Chromosomes and Cancer 50 (11), 896-907, 2011 | 69 | 2011 |
| Activated ALK signals through the ERK–ETV5–RET pathway to drive neuroblastoma oncogenesis L Lopez-Delisle, C Pierre-Eugène, C Louis-Brennetot, D Surdez, ... Oncogene 37 (11), 1417-1429, 2018 | 67 | 2018 |
| Frequent Ki-ras mutations in gastric tumors of the MSI phenotype C Brennetot, A Duval, R Hamelin, M Pinto, C Oliveira, R Seruca, ... Gastroenterology 125 (4), 1282-1283, 2003 | 32 | 2003 |
| Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of … M Benchetritt, V Hofman, N Vénissac, C Brennetot, A Italiano, A Aurias, ... Cancer genetics and cytogenetics 179 (2), 150-155, 2007 | 29 | 2007 |
| Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma C Thirant, A Peltier, S Durand, A Kramdi, C Louis-Brennetot, ... Nature Communications 14 (1), 2575, 2023 | 25 | 2023 |
| Ovarian dysgerminoma and Apert syndrome C Rouzier, C Soler, P Hofman, C Brennetot, E Bieth, F Pedeutour Pediatric blood & cancer 50 (3), 696-698, 2008 | 25 | 2008 |
